1. Home
  2. PRCT vs SUPN Comparison

PRCT vs SUPN Comparison

Compare PRCT & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRCT
  • SUPN
  • Stock Information
  • Founded
  • PRCT 2009
  • SUPN 2005
  • Country
  • PRCT United States
  • SUPN United States
  • Employees
  • PRCT N/A
  • SUPN N/A
  • Industry
  • PRCT Medical Specialities
  • SUPN Biotechnology: Pharmaceutical Preparations
  • Sector
  • PRCT Health Care
  • SUPN Health Care
  • Exchange
  • PRCT Nasdaq
  • SUPN Nasdaq
  • Market Cap
  • PRCT 2.2B
  • SUPN 2.0B
  • IPO Year
  • PRCT 2021
  • SUPN 2012
  • Fundamental
  • Price
  • PRCT $40.62
  • SUPN $45.93
  • Analyst Decision
  • PRCT Strong Buy
  • SUPN Buy
  • Analyst Count
  • PRCT 8
  • SUPN 2
  • Target Price
  • PRCT $73.63
  • SUPN $43.00
  • AVG Volume (30 Days)
  • PRCT 1.3M
  • SUPN 793.2K
  • Earning Date
  • PRCT 10-27-2025
  • SUPN 11-03-2025
  • Dividend Yield
  • PRCT N/A
  • SUPN N/A
  • EPS Growth
  • PRCT N/A
  • SUPN 1411.53
  • EPS
  • PRCT N/A
  • SUPN 1.14
  • Revenue
  • PRCT $274,950,000.00
  • SUPN $665,125,000.00
  • Revenue This Year
  • PRCT $48.38
  • SUPN $4.84
  • Revenue Next Year
  • PRCT $30.87
  • SUPN $17.69
  • P/E Ratio
  • PRCT N/A
  • SUPN $39.49
  • Revenue Growth
  • PRCT 55.71
  • SUPN 5.55
  • 52 Week Low
  • PRCT $37.12
  • SUPN $29.16
  • 52 Week High
  • PRCT $103.81
  • SUPN $45.94
  • Technical
  • Relative Strength Index (RSI)
  • PRCT 42.58
  • SUPN 73.73
  • Support Level
  • PRCT $37.18
  • SUPN $44.10
  • Resistance Level
  • PRCT $42.43
  • SUPN $45.94
  • Average True Range (ATR)
  • PRCT 1.62
  • SUPN 1.10
  • MACD
  • PRCT 0.55
  • SUPN -0.14
  • Stochastic Oscillator
  • PRCT 65.52
  • SUPN 96.29

About PRCT PROCEPT BioRobotics Corporation

PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, which are image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.

Share on Social Networks: